📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Inclusion of chemotherapy in addition to anthracycline in the treatment of acute promyelocytic leukaemia does not improve outcomes: results of the MRC AML15 trial. (2013)

First Author: Burnett AK

Attributed to: MRC Centre for Transplantation funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/leu.2012.360

PubMed Identifier: 23222369

Publication URI: http://europepmc.org/abstract/MED/23222369

Type: Journal Article/Review

Volume: 27

Parent Publication: Leukemia

Issue: 4

ISSN: 0887-6924